SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000878088-09-000041
Filing Date
2009-06-19
Accepted
2009-06-19 16:15:48
Documents
5
Period of Report
2009-06-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8kfspapb141june192009.htm 8-K 23481
2 SELECTED FINANCIAL DATA exhibit99_1.htm EX-99.1 105996
3 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA exhibit99_2.htm EX-99.2 269335
4 CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA exhibit99_3.htm EX-99.3 1043310
5 CONTROLS AND PROCEDURES exhibit99_4.htm EX-99.4 7074
  Complete submission text file 0000878088-09-000041.txt   1450792
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10827 | Film No.: 09901612
SIC: 2834 Pharmaceutical Preparations